Skip to Main Content

An official website of the United States government

Here you can browse the complete list of publications for PLCO

Publication Year
Title PubMed Authors Journal Year Studies
Associations between unprocessed red and processed meat, poultry, seafood and egg intake and the risk of prostate cancer: A pooled analysis of 15 prospective cohort studies. 26685908 Wu K, Spiegelman D, Hou T, Albanes D, Allen NE, Berndt SI, van den Brandt PA, Giles GG, Giovannucci E, Alexandra Goldbohm R, Goodman GG, Goodman PJ, Håkansson N, Inoue M, Key TJ, Kolonel LN, Männistö S, McCullough ML, Neuhouser ML, Park Y, Platz EA,… Int. J. Cancer 2016 PLCO
Alcohol consumption and breast cancer risk by estrogen receptor status: in a pooled analysis of 20 studies. 26320033 Jung S, Wang M, Anderson K, Baglietto L, Bergkvist L, Bernstein L, van den Brandt PA, Brinton L, Buring JE, Eliassen AH, Falk R, Gapstur SM, Giles GG, Goodman G, Hoffman-Bolton J, Horn-Ross PL, Inoue M, Kolonel LN, Krogh V, Lof M, Maas P, Miller AB,… Int J Epidemiol 2016 PLCO
Genetic variants in cell cycle control pathway confer susceptibility to aggressive prostate carcinoma. 26708993 Kibel AS, Ahn J, Isikbay M, Klim A, Wu WS, Hayes RB, Isaacs WB, Daw EW The Prostate 2016 PLCO
A prospective study of angiogenic markers and postmenopausal breast cancer risk in the prostate, lung, colorectal, and ovarian cancer screening trial. 27357932 Falk RT, Staff AC, Bradwin G, Karumanchi SA, Troisi R Cancer causes & control : CCC 2016 PLCO
Essential Nutrient Interactions: Does Low or Suboptimal Magnesium Status Interact with Vitamin D and/or Calcium Status? 26773013 Rosanoff A, Dai Q, Shapses SA Adv Nutr 2016 PLCO
Calcium/magnesium intake ratio, but not magnesium intake, interacts with genetic polymorphism in relation to colorectal neoplasia in a two-phase study. 26333203 Zhu X, Shrubsole MJ, Ness RM, Hibler EA, Cai Q, Long J, Chen Z, Li G, Jiang M, Hou L, Kabagambe EK, Zhang B, Smalley WE, Edwards TL, Giovannucci EL, Zheng W, Dai Q Mol Carcinog 2016 PLCO
Low Levels of Circulating Adiponectin Are Associated with Multiple Myeloma Risk in Overweight and Obese Individuals 26921332 Jonathan N Hofmann 1, Brenda M Birmann 2, Lauren R Teras 3, Ruth M Pfeiffer 4, Ye Wang 5, Demetrius Albanes 4, Dalsu Baris 4, Graham A Colditz 6, Anneclaire J De Roos 7, Graham G Giles 8, H Dean Hosgood 9, Qing Lan 4, Ola Landgren 10, Linda M Liao 4… Cancer Res 2016 PLCO
Lung cancer detectability by test, histology, stage, and gender: estimates from the NLST and the PLCO trials. 25312998 Ten Haaf K, van Rosmalen J, de Koning HJ Cancer Epidemiol. Biomarkers Prev. 2015 NLST, PLCO
Renal-cell carcinoma risk estimates based on participants in the prostate, lung, colorectal, and ovarian cancer screening trial and national lung screening trial. 26602092 Lotan Y, Karam JA, Shariat SF, Gupta A, Roupret M, Bensalah K, Margulis V Urol. Oncol. 2015 NLST, PLCO
Data Processing and Analytic Support in the PLCO Cancer Screening Trial. 26238116 Mabie J, Riley T, Marcus PM, Black A, Rozjabek H, Yu K, Young M, Austin J, Rathmell J, Williams C, Prorok PC Rev Recent Clin Trials 2015 PLCO
The PLCO Cancer Screening Trial: Background, Goals, Organization, Operations, Results. 26238115 Gohagan JK, Prorok PC, Greenwald P, Kramer BS Rev Recent Clin Trials 2015 NLST, PLCO
The PLCO Biorepository: Creating, Maintaining, and Administering a Unique Biospecimen Resource. 26238117 Carrick DM, Black A, Gohagan JK, Khan A, Pettit K, Williams C, Yu K, Yurgalevitch S, Huang WY, Zhu C Rev Recent Clin Trials 2015 PLCO
Comprehensive Quality Management (CQM) in the PLCO Trial. 26238118 Gohagan JK, O'Brien B, Hasson MA, Umbel KD, Bridgeman B, Kramer BS, Reding D, Gren L, Wright P, Riley T, Prorok PC Rev Recent Clin Trials 2015 PLCO
Changes in and Impact of the Death Review Process in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial. 26238119 Miller AB, Feld R, Fontana R, Gohagan JK, Jatoi I, Lawrence W, Miller A, ProroK PC, Rajput A, Sherman M, Welch G, Wright P, Yurgalevitch S, Albertsen P Rev Recent Clin Trials 2015 PLCO
Validation of Self-Report of Chest X-Ray Exam at a Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial Center. 26238206 Gren LH, Lamerato LE, Wright P, Marcus PM Rev Recent Clin Trials 2015 PLCO
Lessons in Medical Record Abstraction from the Prostate, Lung, Colorectal, and Ovarian (PLCO) National Screening Trial. 26238207 Bazzi L, Lamerato LE, Varner J, Shambaugh VL, Cordes JE, Ragard LR, Marcus PM Rev Recent Clin Trials 2015 PLCO
Building Successful Relationships in the PLCO Cancer Screening Trial. 26238208 Marcus PM, Broski KG, Buys SS, Childs J, Church TR, Gohagan JK, Gren LH, Higgins D, Jaggi R, Jenkins V, Johnson CC, Lappe K, O'Brien B, Ogden SL, Prorok PC, Reding D, Shambaugh V, Yokochi LA, Yurgalevitch S Rev Recent Clin Trials 2015 PLCO
Coffee, tea, caffeine intake, and the risk of cancer in the PLCO cohort. 26291054 Hashibe M, Galeone C, Buys SS, Gren L, Boffetta P, Zhang ZF, La Vecchia C Br. J. Cancer 2015 PLCO
Efficacy of Prostate-Specific Antigen Screening: Use of Regression Discontinuity in the PLCO Cancer Screening Trial. 26291583 Shoag J, Halpern J, Eisner B, Lee R, Mittal S, Barbieri CE, Shoag D JAMA Oncol 2015 PLCO
Finasteride Reduces Risk of Bladder Cancer in a Large Prospective Screening Study. 26320383 Morales EE, Grill S, Svatek RS, Kaushik D, Thompson IM, Ankerst DP, Liss MA Eur. Urol. 2015 PLCO